Serum contains all the clotting factors, except
**Core Concept**
The coagulation cascade involves a series of enzyme-activated reactions that ultimately lead to the formation of a fibrin clot. Serum, which is the component of blood that remains after clotting, contains most of the clotting factors. However, there is one exception: Factor VIII, also known as antihemophilic factor (AHF), is primarily synthesized in the liver but is also produced in endothelial cells and has an unusually high concentration in plasma due to its binding to von Willebrand factor (VWF).
**Why the Correct Answer is Right**
Factor VIII is an essential component of the intrinsic pathway of blood coagulation. It acts as a cofactor for Factor IXa in the activation of Factor X to Factor Xa. In the absence of Factor VIII, patients with hemophilia A develop severe bleeding disorders. Unlike other clotting factors, Factor VIII is not stable in serum, as it is rapidly inactivated by heat, acid, and proteolytic enzymes. This unique characteristic makes it difficult to measure in serum.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because Factor II (prothrombin) is a clotting factor that can be measured in serum. It undergoes a series of transformations, including carboxylation and gamma-carboxylation, to become the active enzyme thrombin, which then converts fibrinogen to fibrin.
* **Option B:** This option is incorrect because Factor V is another clotting factor present in serum. It serves as a cofactor for the Factor Xa-mediated activation of prothrombin to thrombin. Deficiencies in Factor V can lead to bleeding disorders.
* **Option C:** This option is incorrect because Factor VII is a clotting factor present in serum. It initiates the extrinsic pathway of coagulation by activating Factor X to Factor Xa, which then activates prothrombin to thrombin.
**Clinical Pearl / High-Yield Fact**
Factor VIII deficiency is the most common cause of inherited bleeding disorders, affecting approximately 1 in 5,000 to 1 in 10,000 individuals. Patients with hemophilia A often develop joint and muscle pain due to recurrent bleeding into these tissues.
**Correct Answer:** D.